US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Lunai Bioworks

1.42

-0.0500-3.40%

Volume:35.15K

Turnover:50.53K

Market Cap:6.44M

PE:-0.02

High:1.60

Open:1.60

Low:1.41

Close:1.47

52wk High:13.28

52wk Low:1.21

Shares:4.53M

Float Shares:2.87M

Volume Ratio:0.71

T/O Rate:1.22%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-61.5200

EPS(LYR):-86.2743

ROE:-325.46%

ROA:-9.65%

PB:-0.67

PE(LYR):-0.02

Loading ...

Overview Company News Filings

Lunai Bioworks regains Nasdaq $1 minimum bid price compliance, enters one-year monitoring period

Lunai Bioworks unit BioSymetrics enters neurology target discovery collaboration with BrainStorm Therapeutics

Lunai Bioworks and Brainstorm Therapeutics Launch Foundation-Funded Parkinson's and Rare Epilepsy AI Discovery Collaboration

THOMSON REUTERS

Lunai Bioworks Inc - Federal Judge Grants Lunai Bioworks Expedited Discovery to Identify "Naked" Short Sellers

THOMSON REUTERS

Lunai Bioworks wins expedited discovery to identify alleged naked short sellers

Lunai Bioworks Inc. trading halted, news pending

Lunai Bioworks to Execute 1-for-8 Reverse Stock Split Effective May 22 to Regain Nasdaq Compliance

Lunai Bioworks announces reverse stock split

Lunai Bioworks effects 1-for-8 reverse stock split May 22

Lunai Bioworks, Inc. Announces Reverse Stock Split

THOMSON REUTERS

Lunai Bioworks Inc. - Common Stock Q3 EPS $(0.10), Sales $20.942K

Benzinga Earnings

Lunai Bioworks Q3 FY26 net loss widens to $2.57 million; revenue $20,942

Lunai Bioworks Inc - Approves Reverse Stock Split at Ratio of 1-for-3 to 1-for-30 - SEC Filing

THOMSON REUTERS

Lunai Bioworks shareholders approved reverse stock split amendment at special meeting

Lunai Bioworks amends 8-K to disclose Nasdaq MVLS noncompliance delisting basis

Lunai Bioworks completes $20 million preferred stock issuance in private placement

Press Release: Lunai Bioworks Completes $20 Million Preferred Issuance to Acquire CNS Delivery and Neurotherapeutic IP

Lunai Bioworks completes Neurobridge IP Holdings merger, issues $20 million preferred stock

Stock Market Today: Dow Jones, S&P 500 Futures Edge Lower Amid Extension Of Israel-Lebanon Ceasefire—Intel, SAP, Lunai Bioworks In Focus

Benzinga Earnings

Lunai Bioworks unit BioSymetrics signs LOI with Geneial on rare disease cohorts

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/LNAI/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LNAI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LNAI\",,,,,undefined,":{"symbol":"LNAI","market":"US","secType":"STK","nameCN":"Lunai Bioworks","latestPrice":1.42,"timestamp":1790882304855,"preClose":1.47,"halted":0,"volume":35149,"delay":0,"changeRate":-0.0340136054421769,"floatShares":2870800,"shares":4533900,"eps":-61.52,"marketStatus":"Trading","change":-0.05,"latestTime":"10-01 15:22:03 EDT","open":1.6,"high":1.6,"low":1.41,"amount":50528.9546105,"amplitude":0.129252,"askPrice":1.42,"askSize":200,"bidPrice":1.35,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-61.52,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1790884800000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":1.47,"preHourTrading":{"tag":"盘前","latestPrice":1.5312,"preClose":1.47,"latestTime":"09:06 EDT","volume":3778,"amount":5910.849876599999,"timestamp":1790859960435,"change":0.0612,"changeRate":0.041633,"amplitude":0.142857},"postHourTrading":{"tag":"盘后","latestPrice":1.47,"preClose":1.47,"latestTime":"19:30 EDT","volume":1640,"amount":2413.3069,"timestamp":1790811002142,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.714957,"impliedVol":1.4337,"impliedVolPercentile":0.85},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LNAI\",,,,,undefined,":{"symbol":"LNAI","floatShares":2870800,"roa":"-9.65%","roe":"-325.46%","lyrEps":-86.274256,"volumeRatio":0.714957,"shares":4533900,"dividePrice":0,"high":1.6,"amplitude":0.129252,"preClose":1.47,"low":1.41,"week52Low":1.2104,"pbRate":"-0.67","psRate":"307.43","week52High":13.28,"institutionHeld":0,"latestPrice":1.42,"committee":-0.333333,"eps":-61.52,"divideRate":0,"volume":35149,"delay":0,"ttmEps":-61.52,"open":1.6,"prevYearClose":7.0536,"prevWeekClose":1.93,"prevMonthClose":1.47,"prevQuarterClose":1.47,"fiveDayClose":1.94,"twentyDayClose":2.4,"sixtyDayClose":2.74},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LNAI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-05-22","symbol":"LNAI","defaultRemindTime":1779456600000,"type":"split","dateTimestamp":1779422400000,"forFactor":8,"toFactor":1,"ratio":8},{"market":"US","date":"2026-05-15","symbol":"LNAI","fiscalQuarterEnding":"2026/03","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778817600000,"reportTimeType":"post","actualEps":-0.1},{"market":"US","date":"2026-02-17","symbol":"LNAI","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1771304400000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2025-11-14","symbol":"LNAI","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"post","actualEps":0.13},{"market":"US","date":"2025-09-30","symbol":"LNAI","defaultRemindTime":1759239000000,"type":"split","dateTimestamp":1759204800000,"forFactor":10,"toFactor":1,"ratio":10}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LNAI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LNAI\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LNAI\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LNAI","date":"2026-09-30","current":-0.023895,"percent":0.959677,"low":-0.265446,"twenty":-0.15939,"median":-0.099666,"eighty":-0.078498,"high":-0.035532,"avg":-0.115949,"sd":0.046533,"marketCap":8024983},"quantilePoints":[{"date":"2025-10-03","current":-0.160171,"twenty":-0.164877,"median":-0.163112,"eighty":-0.161348,"marketCap":28511703},{"date":"2025-10-10","current":-0.161474,"twenty":-0.165919,"median":-0.164078,"eighty":-0.161474,"marketCap":28743506},{"date":"2025-10-17","current":-0.158869,"twenty":-0.16512,"median":-0.161474,"eighty":-0.158869,"marketCap":28279901},{"date":"2025-10-24","current":-0.135429,"twenty":-0.16512,"median":-0.160171,"eighty":-0.152098,"marketCap":24107456},{"date":"2025-10-31","current":-0.122514,"twenty":-0.163557,"median":-0.158218,"eighty":-0.135687,"marketCap":21808324},{"date":"2025-11-07","current":-0.132813,"twenty":-0.161474,"median":-0.152344,"eighty":-0.130739,"marketCap":23641716},{"date":"2025-11-14","current":-0.134115,"twenty":-0.161474,"median":-0.143888,"eighty":-0.121701,"marketCap":23873497},{"date":"2025-11-21","current":-0.254829,"twenty":-0.163557,"median":-0.147149,"eighty":-0.123011,"marketCap":33376540},{"date":"2025-11-28","current":-0.211108,"twenty":-0.166054,"median":-0.152344,"eighty":-0.125001,"marketCap":27650221},{"date":"2025-12-05","current":-0.232577,"twenty":-0.211108,"median":-0.158218,"eighty":-0.130221,"marketCap":30462108},{"date":"2025-12-12","current":-0.20753,"twenty":-0.221843,"median":-0.160171,"eighty":-0.132813,"marketCap":27181573},{"date":"2025-12-19","current":-0.184259,"twenty":-0.212897,"median":-0.161474,"eighty":-0.134115,"marketCap":24133572},{"date":"2025-12-26","current":-0.176388,"twenty":-0.211466,"median":-0.164729,"eighty":-0.134115,"marketCap":23102623},{"date":"2026-01-02","current":-0.157729,"twenty":-0.211108,"median":-0.164729,"eighty":-0.134896,"marketCap":20658806},{"date":"2026-01-09","current":-0.162828,"twenty":-0.208961,"median":-0.16538,"eighty":-0.135424,"marketCap":21326580},{"date":"2026-01-16","current":-0.16442,"twenty":-0.206179,"median":-0.165717,"eighty":-0.136203,"marketCap":21535113},{"date":"2026-01-23","current":-0.164223,"twenty":-0.200455,"median":-0.16538,"eighty":-0.13724,"marketCap":21509339},{"date":"2026-01-30","current":-0.150287,"twenty":-0.192502,"median":-0.16442,"eighty":-0.139063,"marketCap":19684091},{"date":"2026-02-06","current":-0.115725,"twenty":-0.190708,"median":-0.163453,"eighty":-0.135462,"marketCap":15157289},{"date":"2026-02-13","current":-0.146316,"twenty":-0.189626,"median":-0.161474,"eighty":-0.135462,"marketCap":19163931},{"date":"2026-02-20","current":-0.111222,"twenty":-0.189268,"median":-0.161474,"eighty":-0.134115,"marketCap":13960941},{"date":"2026-02-27","current":-0.077077,"twenty":-0.187121,"median":-0.158869,"eighty":-0.128849,"marketCap":9674942},{"date":"2026-03-06","current":-0.069658,"twenty":-0.184259,"median":-0.157729,"eighty":-0.122516,"marketCap":8743729},{"date":"2026-03-13","current":-0.037035,"twenty":-0.183139,"median":-0.156666,"eighty":-0.116398,"marketCap":4648809},{"date":"2026-03-20","current":-0.074186,"twenty":-0.178206,"median":-0.153221,"eighty":-0.113305,"marketCap":9312132},{"date":"2026-03-27","current":-0.095113,"twenty":-0.176388,"median":-0.150672,"eighty":-0.107552,"marketCap":11938878},{"date":"2026-04-02","current":-0.079389,"twenty":-0.176388,"median":-0.150189,"eighty":-0.092492,"marketCap":9965190},{"date":"2026-04-10","current":-0.079794,"twenty":-0.175994,"median":-0.147149,"eighty":-0.079794,"marketCap":10015984},{"date":"2026-04-17","current":-0.058578,"twenty":-0.173812,"median":-0.143919,"eighty":-0.0791,"marketCap":7352956},{"date":"2026-04-24","current":-0.088046,"twenty":-0.173794,"median":-0.139607,"eighty":-0.079389,"marketCap":11051809},{"date":"2026-05-01","current":-0.095356,"twenty":-0.173686,"median":-0.136115,"eighty":-0.079543,"marketCap":11969469},{"date":"2026-05-08","current":-0.096223,"twenty":-0.172094,"median":-0.135417,"eighty":-0.079543,"marketCap":12078282},{"date":"2026-05-15","current":-0.079926,"twenty":-0.171736,"median":-0.133464,"eighty":-0.079794,"marketCap":10032591},{"date":"2026-05-22","current":-0.082023,"twenty":-0.169948,"median":-0.130221,"eighty":-0.079389,"marketCap":10522249},{"date":"2026-05-29","current":-0.107441,"twenty":-0.168989,"median":-0.126835,"eighty":-0.079331,"marketCap":13783022},{"date":"2026-06-05","current":-0.1032,"twenty":-0.168377,"median":-0.122519,"eighty":-0.079512,"marketCap":13238955},{"date":"2026-06-12","current":-0.088356,"twenty":-0.168045,"median":-0.119258,"eighty":-0.079543,"marketCap":11334722},{"date":"2026-06-18","current":-0.14137,"twenty":-0.167069,"median":-0.118498,"eighty":-0.079694,"marketCap":18135556},{"date":"2026-06-26","current":-0.12582,"twenty":-0.166216,"median":-0.121361,"eighty":-0.079842,"marketCap":16140644},{"date":"2026-07-02","current":-0.109209,"twenty":-0.16583,"median":-0.118878,"eighty":-0.079874,"marketCap":14009717},{"date":"2026-07-10","current":-0.096485,"twenty":-0.165448,"median":-0.115725,"eighty":-0.079895,"marketCap":12377516},{"date":"2026-07-17","current":-0.101787,"twenty":-0.16538,"median":-0.113965,"eighty":-0.08033,"marketCap":13057600},{"date":"2026-07-24","current":-0.081995,"twenty":-0.165046,"median":-0.113282,"eighty":-0.081349,"marketCap":10518622},{"date":"2026-07-31","current":-0.071392,"twenty":-0.16452,"median":-0.112744,"eighty":-0.079874,"marketCap":9158455},{"date":"2026-08-07","current":-0.085529,"twenty":-0.164381,"median":-0.110215,"eighty":-0.079874,"marketCap":10972011},{"date":"2026-08-14","current":-0.079167,"twenty":-0.164194,"median":-0.108855,"eighty":-0.079874,"marketCap":10155911},{"date":"2026-08-21","current":-0.077754,"twenty":-0.163828,"median":-0.107366,"eighty":-0.079525,"marketCap":9974555},{"date":"2026-08-28","current":-0.083055,"twenty":-0.162557,"median":-0.105321,"eighty":-0.079211,"marketCap":10654639},{"date":"2026-09-04","current":-0.083055,"twenty":-0.161474,"median":-0.104854,"eighty":-0.079211,"marketCap":10654639},{"date":"2026-09-11","current":-0.086059,"twenty":-0.161474,"median":-0.103553,"eighty":-0.079389,"marketCap":11040019},{"date":"2026-09-18","current":-0.080404,"twenty":-0.161474,"median":-0.101433,"eighty":-0.079167,"marketCap":10314597},{"date":"2026-09-25","current":-0.068565,"twenty":-0.160171,"median":-0.100285,"eighty":-0.078814,"marketCap":8795744},{"date":"2026-09-30","current":-0.062556,"twenty":-0.15939,"median":-0.099666,"eighty":-0.078498,"marketCap":8024983}],"updateTime":1790858975169},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LNAI\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2644176745","title":"Lunai Bioworks regains Nasdaq $1 minimum bid price compliance, enters one-year monitoring period","url":"https://stock-news.laohu8.com/highlight/detail?id=2644176745","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644176745?lang=en_us&edition=fundamental","pubTime":"2026-06-17 04:01","pubTimestamp":1781640101,"startTime":"0","endTime":"0","summary":"Lunai Bioworks regained compliance with Nasdaq’s $1 minimum bid price rule, clearing a key listing risk flagged in prior panel extensions.Nasdaq imposed a mandatory one-year panel monitor starting June 11, 2026.A fresh bid-price breach during monitoring would trigger an immediate delisting determination, with no compliance plan or added cure period available.The company would still be able to request a new Nasdaq Hearings Panel hearing, which would stay any suspension or delisting pending the outcome.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lunai Bioworks Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities an","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nNDLbpcr4D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638696607","title":"Lunai Bioworks unit BioSymetrics enters neurology target discovery collaboration with BrainStorm Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2638696607","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638696607?lang=en_us&edition=fundamental","pubTime":"2026-05-28 21:15","pubTimestamp":1779974129,"startTime":"0","endTime":"0","summary":"Lunai Bioworks’ wholly owned subsidiary BioSymetrics signed a strategic collaboration LOI with BrainStorm Therapeutics to discover neurology drug targets.LouLou Foundation grant backs initial work in rare genetic epilepsies; broader scope includes Parkinson’s disease programs.BioSymetrics will pair its AI target discovery with zebrafish in vivo validation, integrated with BrainStorm’s human-derived brain organoid systems.Parkinson’s effort combines BrainStorm’s midbrain organoid foundation model with BioSymetrics’ analysis of the PPMI dataset to identify progression biomarkers.Companies aim to generate validated, partnerable neurology assets for licensing or downstream development.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nNDL7Rwc79:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638069669","title":"Lunai Bioworks and Brainstorm Therapeutics Launch Foundation-Funded Parkinson's and Rare Epilepsy AI Discovery Collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2638069669","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638069669?lang=en_us&edition=fundamental","pubTime":"2026-05-28 21:15","pubTimestamp":1779974101,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nTUAYMJQX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LNAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637129843","title":"Lunai Bioworks Inc - Federal Judge Grants Lunai Bioworks Expedited Discovery to Identify \"Naked\" Short Sellers","url":"https://stock-news.laohu8.com/highlight/detail?id=2637129843","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637129843?lang=en_us&edition=fundamental","pubTime":"2026-05-22 21:16","pubTimestamp":1779455817,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nFWN41Z105:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LNAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637312607","title":"Lunai Bioworks wins expedited discovery to identify alleged naked short sellers","url":"https://stock-news.laohu8.com/highlight/detail?id=2637312607","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637312607?lang=en_us&edition=fundamental","pubTime":"2026-05-22 21:15","pubTimestamp":1779455735,"startTime":"0","endTime":"0","summary":"Lunai Bioworks won a court order in Delaware allowing expedited third-party discovery to identify unnamed defendants it alleges engaged in “naked” short selling of its Nasdaq-listed common stock in late 2025 and the first half of 2026.The magistrate judge found good cause for early discovery, citing a prima facie showing on at least some claims and the need to obtain identifying information held by broker-dealers, custodians, market infrastructure entities, or market participants.The lawsuit, filed May 11, 2026, alleges securities fraud under Section 10 and Rule 10b-5, market manipulation under Section 9, and wire fraud as an intentional tort, seeking damages and injunctive relief.The case targets “John Doe” defendants pending identification through discovery, with the company signaling it may later add civil RICO claims that could increase potential damages.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nNDLbqPLSn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LNAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637363609","title":"Lunai Bioworks Inc. trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2637363609","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637363609?lang=en_us&edition=fundamental","pubTime":"2026-05-22 07:50","pubTimestamp":1779407436,"startTime":"0","endTime":"0","summary":"19:50 EDT Lunai Bioworks (LNAI) Inc. trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving brea...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lunai-bioworks-inc-trading-halted-news-pending-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lunai-bioworks-inc-trading-halted-news-pending-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LNAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195656015","title":"Lunai Bioworks to Execute 1-for-8 Reverse Stock Split Effective May 22 to Regain Nasdaq Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=1195656015","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195656015?lang=en_us&edition=fundamental","pubTime":"2026-05-21 03:11","pubTimestamp":1779304289,"startTime":"0","endTime":"0","summary":"The AI-driven life sciences company Lunai Bioworks announced on Wednesday a 1-for-8 reverse split of its common stock. The consolidation will become effective at 12:01 a.m. Eastern Time on May 22,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07522","GPIQ","LNAI","NVIW.SI","NAPR","07261","QQQM","QYLG","TQQQ","PSQ","JEPQ","NOCT","QMAR","BK4139","IYW","QDTE","TQQY","QQQX","03034","BK4007","QLD","NJAN","QQQE","FTEC","QDEC","07266","09086","QQQA","QQQY","QQQJ","QQQ","SQQQ","02834","MNQmain","03455","07568","NJUL","QID","09834","BK1147","ONEQ","TECS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636455840","title":"Lunai Bioworks announces reverse stock split","url":"https://stock-news.laohu8.com/highlight/detail?id=2636455840","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636455840?lang=en_us&edition=fundamental","pubTime":"2026-05-20 21:21","pubTimestamp":1779283265,"startTime":"0","endTime":"0","summary":"Lunai Bioworks (LNAI) announced that it will effect a reverse stock split of its issued and outstanding common stock, par value $0.0001 per share, ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lunai-bioworks-announces-reverse-stock-split-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lunai-bioworks-announces-reverse-stock-split-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LNAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636642840","title":"Lunai Bioworks effects 1-for-8 reverse stock split May 22","url":"https://stock-news.laohu8.com/highlight/detail?id=2636642840","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636642840?lang=en_us&edition=fundamental","pubTime":"2026-05-20 21:15","pubTimestamp":1779282922,"startTime":"0","endTime":"0","summary":"Lunai Bioworks will carry out a 1-for-8 reverse stock split effective 12:01 a.m. ET on May 22, 2026.Shares are set to trade on a split-adjusted basis on Nasdaq at the open on May 22 under the LNAI ticker.The move targets a higher share price to help regain compliance with Nasdaq’s $1 minimum bid requirement.Issued shares are expected to drop to about 4,533,890 from about 36,271,119, subject to rounding for fractional shares.A new CUSIP, 29350E302, will take effect following the split.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nNDLc76XMp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636840663","title":"Lunai Bioworks, Inc. Announces Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2636840663","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636840663?lang=en_us&edition=fundamental","pubTime":"2026-05-20 21:15","pubTimestamp":1779282902,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nTUA4H1RSQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LNAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635055865","title":"Lunai Bioworks Inc. - Common Stock Q3 EPS $(0.10), Sales $20.942K","url":"https://stock-news.laohu8.com/highlight/detail?id=2635055865","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635055865?lang=en_us&edition=fundamental","pubTime":"2026-05-16 06:19","pubTimestamp":1778883561,"startTime":"0","endTime":"0","summary":"Lunai Bioworks Inc. - Common Stock (NASDAQ:LNAI) reported quarterly losses of $(0.10) per share.  The company reported $20.942 thousand in sales this quarter.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52620268/lunai-bioworks-inc-common-stock-q3-eps-0-10-sales-20-942k","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JEPQ","NVIW.SI","ONEQ","QYLG","SQQQ","MNQmain","NDX","NQmain","TQQQ","QID",".IXIC","PSQ","QQQM","IYW","QLD","QQQJ","QQQ","TECS","TQQY","GPIQ","LNAI","QQQE","QQQA","FTEC","BK4139","QDTE","QQQY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635058308","title":"Lunai Bioworks Q3 FY26 net loss widens to $2.57 million; revenue $20,942","url":"https://stock-news.laohu8.com/highlight/detail?id=2635058308","media":"Reuters","labels":["dataReport","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635058308?lang=en_us&edition=fundamental","pubTime":"2026-05-16 04:50","pubTimestamp":1778878241,"startTime":"0","endTime":"0","summary":"Lunai Bioworks posted a net loss of USD 2.57 million for quarter ended March 31, 2026, swinging from net income of USD 189,176 a year earlier as operating loss narrowed 66% to USD 1.43 million.Revenue was USD 20,942, compared with no revenue a year earlier, while operating expenses fell 65% to USD 1.45 million on a 66% drop in general and administrative costs to USD 1.42 million.Cash and cash equivalents totaled USD 3.16 million at March 31, 2026, up from USD 92,700 at June 30, 2025, while working capital deficit narrowed 45% to USD 15.55 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lunai Bioworks Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retr","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDL9VSRR7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"Lunai Bioworks Q3 FY26 net loss widens to $2.57 million; revenue $20,942","news_tag":"dataReport,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635756354","title":"Lunai Bioworks Inc - Approves Reverse Stock Split at Ratio of 1-for-3 to 1-for-30 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2635756354","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635756354?lang=en_us&edition=fundamental","pubTime":"2026-05-14 04:51","pubTimestamp":1778705506,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nFWN41Q1IQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LNAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635755009","title":"Lunai Bioworks shareholders approved reverse stock split amendment at special meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2635755009","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635755009?lang=en_us&edition=fundamental","pubTime":"2026-05-14 04:46","pubTimestamp":1778705194,"startTime":"0","endTime":"0","summary":"Lunai Bioworks held a special shareholder meeting on May 8, 2026.Shareholders authorized an amendment to the certificate of incorporation to allow a reverse stock split, with the ratio to be set by the board within a 1-for-3 to 1-for-30 range.The vote did not confirm the reverse split has been implemented.Investors also backed a measure to adjourn the meeting if needed to seek additional proxies to pass the reverse-split authorization.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lunai Bioworks Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 13, 2026, and is solely responsible ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nNDLqkQ6k:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LNAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634157253","title":"Lunai Bioworks amends 8-K to disclose Nasdaq MVLS noncompliance delisting basis","url":"https://stock-news.laohu8.com/highlight/detail?id=2634157253","media":"Reuters","labels":["shareholding","policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634157253?lang=en_us&edition=fundamental","pubTime":"2026-05-12 05:31","pubTimestamp":1778535073,"startTime":"0","endTime":"0","summary":"Lunai Bioworks filed an amended Form 8-K to update its earlier report with an additional Nasdaq staff determination letter received April 28, 2026.Letter warned continued failure to meet Nasdaq Listing Rule 5550 market value of listed securities threshold of $35 million, with grace period expiring April 27, 2026, could serve as an additional basis for delisting.Nasdaq Hearings Panel previously granted an exception through May 1, 2026 to regain compliance via stockholders’ equity alternative, with bid-price compliance deadline set for June 1, 2026.Stockholders authorized a reverse stock split range of 1-for-3 to 1-for-30 on May 8, 2026, with company seeking a short extension to meet bid-price rule following a meeting delay.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as finan","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nNDL6Yn9ph:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632956918","title":"Lunai Bioworks completes $20 million preferred stock issuance in private placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2632956918","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632956918?lang=en_us&edition=fundamental","pubTime":"2026-05-04 21:35","pubTimestamp":1777901723,"startTime":"0","endTime":"0","summary":"The company issued Series B Preferred Stock with an aggregate stated value of $20 million.The funds are intended to support the acquisition of CNS delivery and neurotherapeutic intellectual property.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nNDLbX1WXY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632561729","title":"Press Release: Lunai Bioworks Completes $20 Million Preferred Issuance to Acquire CNS Delivery and Neurotherapeutic IP","url":"https://stock-news.laohu8.com/highlight/detail?id=2632561729","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632561729?lang=en_us&edition=fundamental","pubTime":"2026-05-04 21:35","pubTimestamp":1777901700,"startTime":"0","endTime":"0","summary":"Transaction Adds Dual BBB Delivery Strategies, Supports Alzheimer's Programs, Combination Therapies, 505 Pathways, and CNS Countermeasure Applications. The acquired intellectual property expands Lunai's ability to connect therapeutic discovery with delivery, supporting a more integrated approach to CNS drug development. By pairing compound design with delivery optimization, the Company is advancing a framework aimed at increasing drug concentration in the brain while reducing systemic exposure. This approach addresses both challenges by combining novel neurotherapeutic compounds with complementary delivery technologies, improving CNS access and enabling multi-agent, combinatorial strategies. Together, the portfolio strengthens Lunai's ability not only to deliver therapeutics to the brain, but to develop and deploy both single-agent and combination therapies that target distinct aspects of disease biology. This approach may be applicable across multiple neurological indications as well ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNAI","BK4588","BK4136","LU2463526074.USD","LU1481600234.SGD","IE00B3T34201.USD","CNS","LU1169590202.USD","LU1487256676.USD","BK4135","BK4585","BBB","LU1481599808.USD","LU1169589451.USD","IP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632628317","title":"Lunai Bioworks completes Neurobridge IP Holdings merger, issues $20 million preferred stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2632628317","media":"Reuters","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632628317?lang=en_us&edition=fundamental","pubTime":"2026-05-02 05:18","pubTimestamp":1777670286,"startTime":"0","endTime":"0","summary":"Lunai Bioworks completed merger of Neurobridge IP Holdings into its wholly owned subsidiary Lunai Bioworks IP on May 1, 2026.Transaction transferred a multi-jurisdictional patent portfolio into Lunai structure.Consideration consisted of 8 shares of Series B Convertible Preferred Stock with aggregate stated value of $20 million.Oncotelic received 5 Series B shares with stated value of $12.5 million.Pelerin Therapeutics received 3 Series B shares with stated value of $7.5 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lunai Bioworks Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission ,","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260501:nNDL900ZLp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629145638","title":"Stock Market Today: Dow Jones, S&P 500 Futures Edge Lower Amid Extension Of Israel-Lebanon Ceasefire—Intel, SAP, Lunai Bioworks In Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2629145638","media":"Benzinga Earnings","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629145638?lang=en_us&edition=fundamental","pubTime":"2026-04-24 17:31","pubTimestamp":1777023061,"startTime":"0","endTime":"0","summary":"U.S. stock futures were mixed on Friday following Thursday&#39;s decline, after President Donald Trump announced the extension of the ceasefire between Israel and Lebanon by three weeks.\n\n\n\nOn Thursday, the Dow Jones index closed 179 points lower as investors gauged the evolving Middle East conflict and a downturn in the software sector.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/equities/26/04/52023332/stock-market-today-dow-jones-sp-500-futures-edge-lower-amid-extension-of-israel-lebanon-ceasefire-intel-sap-lunai-bioworks-in-focus","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GB00BDT5M118.USD","LU1868837136.USD","BK4550","SPMO","LINT","LU0321505439.SGD","IVW","INTC","SPDN","CAST","VTI","IVV","SPYD","LU1162221912.USD","BK4588","SSO","VV","SG9999014567.USD","BK4504","BK4613","SH","IE00BKDWB100.SGD","SPUU","BK4585","SAP","BK4581","SPYU","XLG","BK4558","LU2242646821.SGD","IE00BLSP4452.SGD","JEPI","LU0124676726.USD","BMAY","BK4534","PG","SPXL","BK4139","LU1585245621.USD","LU1914381329.SGD","SPYV","SG9999014542.SGD","SG9999014575.USD","BK4559","LU1868836591.USD","SFY","LU0234572021.USD","LU0323591593.USD","ITOT","BK4612","GPIX","BK4528","LU1280957306.USD","LU0081259029.USD","SPLV","YSPY","LU0097036916.USD","INTW","SG9999014559.SGD","LU0096364046.USD","LU2097829019.USD","SPYQ","XDTE","BK4515","BK4533","LU0320765646.SGD","LU0689626769.HKD","LU0237698245.USD","BK4561","SPYI","BK4602","LU2129689514.USD","LU1430594728.SGD","04335","IE00B3T34201.USD","MESmain","GSLC","SG9999001440.SGD","BK4018","BK4543","LU1868837300.USD","LU0321505868.SGD","IE000M9KFDE8.USD","LU1868836757.USD","OEF","LNAI","LU2129689431.USD","ALLW","LU2129689605.HKD","LU2242652126.USD","BK4141","XYLD","IE00BWXC8680.SGD","BK4535","BK4575","BK4579","SPUS","OEX","SPYM","VBK","MOAT","SPYG","SG9999015341.SGD","VTV","LU0942090050.USD","LU2543165471.USD","BK4567","BK4108","HIBL","IE00B1XK9C88.USD","LU2931357623.SGD","ETFT","LU0098860793.USD","TSPY","LU2089985449.USD","SPGP","TECL","VEU","LU2552382058.USD","UPRO","LU2148611432.USD","IJR","ACWI","BK4512","IE00BBT3K403.USD","IVE","SG9999002232.USD","NOBL","BK4593","SPHQ","ESmain","SG9999015358.SGD","LU0868494708.USD","BK4527","DBSC","LU1066053197.SGD","SG9999002224.SGD","SPXS","SCHB","IE00BLSP4239.USD","LU1868836914.USD","LU0868494617.USD","LU0640476718.USD","HIBS","LU0274383776.USD","IJH","LU1929549753.HKD","IE00BN8TJ469.HKD","LU2552382215.SGD","SDS","LU0094547139.USD","SPHD","BK4023","LU2552382132.HKD","LU0061475181.USD","LU0234570918.USD","RSP","BK4529","LU1066051498.USD","BK4605","SPXU","SCHX","BK4554"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627128759","title":"Lunai Bioworks unit BioSymetrics signs LOI with Geneial on rare disease cohorts","url":"https://stock-news.laohu8.com/highlight/detail?id=2627128759","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627128759?lang=en_us&edition=fundamental","pubTime":"2026-04-15 21:10","pubTimestamp":1776258650,"startTime":"0","endTime":"0","summary":"Lunai Bioworks unit BioSymetrics signed a non-binding letter of intent with Geneial to pursue a strategic collaboration in rare neurological disorders.Partnership targets creation of trial-ready patient cohorts by integrating patient-led datasets across multiple registries with longitudinal clinical data.Companies aim to use resulting cohorts to support commercial partnerships with pharmaceutical and biotechnology groups, creating potential revenue-generating collaborations.Initial focus covers select rare neurodevelopmental disorders, with plans to expand program scope over time.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nNDL59NqSx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":42,"code":"91000000","status":"200"}]}}